Search Results - "ANDRE OLAUSSEN, Ken"
-
1
Cisplatin Resistance Associated with PARP Hyperactivation
Published in Cancer research (Chicago, Ill.) (01-04-2013)“…Non-small cell lung carcinoma patients are frequently treated with cisplatin (CDDP), most often yielding temporary clinical responses. Here, we show that PARP1…”
Get full text
Journal Article -
2
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC
Published in Clinical cancer research (01-09-2011)“…Excision repair cross-complementation group 1 (ERCC1) is a protein involved in repair of DNA platinum adducts and stalled DNA replication forks. We and others…”
Get full text
Journal Article -
3
ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform
Published in Cell cycle (Georgetown, Tex.) (15-10-2013)“…ERCC1 (excision repair cross-complementation group 1) plays essential roles in the removal of DNA intrastrand crosslinks by nucleotide excision repair, and…”
Get full text
Journal Article -
4
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Published in Nature reviews. Clinical oncology (01-09-2009)“…KRAS mutations can be predictive of resistance to anti-EGFR monoclonal-based therapy in patients with colorectal cancer. Only limited studies, however, have…”
Get full text
Journal Article -
5
PARP inhibitors: an interesting pathway also for non-small cell lung cancer?
Published in Current pharmaceutical design (01-01-2014)“…Treatment of lung cancer is improving, also based on the identification of molecular characteristics of the tumor, of which some already constitute promising…”
Get more information
Journal Article -
6
A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin
Published in Cancer biology & therapy (15-10-2009)“…Commentary to: The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP Jing-Jing Li, Ya Ding, Dan-Dan…”
Get full text
Journal Article -
7
Prognostic value of LIPC in non-small cell lung carcinoma
Published in Cell cycle (Georgetown, Tex.) (15-02-2013)“…Non-small cell lung carcinoma (NSCLC) is the most common form of lung cancer and is associated with a high mortality rate worldwide. The majority of…”
Get full text
Journal Article -
8
The "Guardian of the Genome"-An Old Key to Unlock the ERCC1 Issue
Published in Clinical cancer research (15-04-2019)“…Excision Repair Cross-Complementation Group 1 (ERCC1) participates in the repair of DNA intrastrand adducts (ISA) and interstrand cross-links, but its role as…”
Get full text
Journal Article -
9
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
Published in The New England journal of medicine (21-03-2013)“…Earlier studies suggested that the response to platinum treatment in lung cancer might be predicted according to the presence or absence of the DNA repair…”
Get full text
Journal Article -
10
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development
Published in Molecular cancer (04-10-2024)“…Understanding the resistance mechanisms of tumor is crucial for advancing cancer therapies. The prospective MATCH-R trial (NCT02517892), led by Gustave Roussy,…”
Get full text
Journal Article -
11
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data
Published in Clinical lung cancer (01-09-2023)“…•Micropapillary/Solid subtype of lung adenocarcinoma is commonly associated with genetic alterations and shows positivity for several biomarkers.•High TMB is…”
Get full text
Journal Article -
12
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer
Published in BMC cancer (15-07-2016)“…Osteopontin (OPN) and thrombospondin-1 (TSP-1) are extracellular matrix proteins secreted by stromal and tumor cells. These proteins appear to have a key role…”
Get full text
Journal Article -
13
Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process
Published in Critical reviews in oncology/hematology (01-05-2008)“…Abstract Telomeres form specialized structures at the ends of eukaryotic chromosomes, preventing them from being wrongly recognized as DNA damage. The human…”
Get full text
Journal Article -
14
ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis
Published in The American journal of pathology (2011)“…The excision repair cross completing group 1 gene product (ERCC1) and the regulatory subunit of ribonucleotide reductase (RRM1) have been reported as being…”
Get full text
Journal Article -
15
DNA repair capacity in circulating lymphocytes and influence on platinum effect in tumor cells
Published in Journal of clinical oncology (01-05-2012)Get full text
Journal Article -
16
No evidence for viral sequences in five lepidic adenocarcinomas (former "BAC") by a high-throughput sequencing approach
Published in BMC research notes (15-12-2015)“…The hypothesis of an infectious etiology of the formerly named bronchiolo-alveolar carcinoma (BAC) has raised controversy. We investigated tumor lung tissues…”
Get full text
Journal Article -
17
Expression of Chemokine Receptor CCR6 as a Molecular Determinant of Adrenal Metastatic Relapse in Patients With Primary Lung Cancer
Published in Clinical lung cancer (01-05-2010)“…Abstract Background Recent studies suggest that chemokines are involved in organ-specific metastatic relapse. We evaluated the potential implications of…”
Get full text
Journal Article -
18
DNA repair pathways and non-small cell lung cancer: clinical perspectives
Published in Bulletin du cancer (01-03-2011)“…The role of DNA repair pathways is to maintain cellular integrity. However, genetic instability is a driving force in the development of tumor cells and many…”
Get more information
Journal Article -
19
Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
Published in Cell reports (Cambridge) (30-08-2012)“…Patients with non-small cell lung cancer (NSCLC) are routinely treated with cytotoxic agents such as cisplatin. Through a genome-wide siRNA-based screen, we…”
Get full text
Journal Article -
20
Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
Published in Cell reports (Cambridge) (01-11-2012)Get full text
Journal Article